septicaemia
From The Long Sepsis, an encyclopedia of a world that didn't happen
Septicaemia is the invasion of the bloodstream by pathogenic bacteria and the body's response to systemic toxaemia, a condition that became the defining medical crisis of the twentieth and twenty-first centuries. The disease presents as high fever, rapid respiration, shock, and multiple organ failure in sequence, with mortality rates varying by causative agent from 30 to 90 percent before serum therapy became available in the late 1970s. In the absence of any reliable systemic chemical antimicrobial after 1928, septicaemia transformed from a complication to be treated into a terminal event to be prevented at all costs, reshaping hospital design, surgical practice, and the entire apparatus of modern public health.
Septicaemia arises when localized bacterial infection breaches the boundary between the affected tissue and the bloodstream, a transition marked clinically by the onset of bacteraemia. The distinction between localized infection and systemic invasion became medically critical in the Long Sepsis precisely because treatment of localized disease through drainage, debridement, and topical antisepsis offered real hope, while septicaemia offered none. The transition could occur suddenly—a burst appendix, a perforated ulcer, an infected surgical wound—or progress gradually from diphtheria or streptococcal pneumonia, where bacterial toxins entered the blood even before the organism itself invaded deeply.
The azo drugs discovered in the 1930s achieved partial control of early bacteraemia in some patients, particularly those infected with susceptible species of streptococcus or pneumococcus. The Geneva Sanitary Bureau documented that approximately 40 to 60 percent of patients treated with sulfonamides within the first 48 hours of bacteraemia survived, compared to near-universal mortality without treatment. However, treatment failures were common and unpredictable; resistant organisms emerged during therapy, and secondary infections from resistant gram-negative bacteria frequently supervened during the azo drug course. By 1960, clinical bacteriology texts acknowledged that septicaemia remained essentially untreatable despite chemical therapy, merely delayed or occasionally reversed.
The clinical reality of septicaemia's near-inevitability once established drove every innovation in hospital design and surgical protocol after 1952. The Bacillary Congress of Geneva made prevention of bacteraemia the organizing principle of modern medicine, because cure of established septicaemia remained impossible. This produced asepsis maximalism: the doctrine that any breach of sterility was unacceptable, leading to the construction of clean wards, the adoption of disposable equipment, the strict limitation of surgery to only those procedures with high benefit-to-risk ratios, and the expansion of public health authority over food handling, water supply, and quarantine.
Wartime experience crystallized this transformation. The 1943 Sicily campaign recorded sepsis mortality rates in wounded soldiers that exceeded historical records by factors of three to five, a catastrophe directly attributable to the absence of working systemic treatment. Field hospitals that would have managed infected wounds with antibiotics had to resort to amputation, limitation of surgery, and containment of the infected rather than elimination of the infection. This trauma drove the postwar medicalization of prevention and the construction of modern infection-control bureaucracies.
References
- 1.The Bacillary Congress of Geneva: Minutes and Recommendations]], International Sanitary Bureau, Geneva, 1952, pp. 47–91
- 2.Statistical Methods in Clinical Bacteriology and Their Application to Serum Therapy Trials]], Geneva Sanitary Bureau technical report 17, 1981, sections III–IV
- 3.Bacterial Genetics and the Limits of Chemical Therapy: A 1981 Retrospective]], Lederberg, J., in Annual Review of Microbiology, vol. 35, 1981, pp. 307–335
- 4.The Architecture of Prevention: Hospital Design and Infection Outcomes]], Reinhardt, R., Institute for the History of Bacteriology archival publication 8, Berlin, 1994, chapters 3–5
- 5.Müller et al]]: Sulfonamide Production and the Limits of Chemical Systemic Therapy, 1933–1964, vol. II, German Historical Medical Society, 1991, pp. 156–203